Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
08/30 U.S. slams EU, but Apple tax demand first issued in Washington
08/29 ALLERGAN : Intas, Auribindo bid $1b for Teva UK portfolio
08/24 Pfizer on buying spree with AstraZeneca antibiotics deal
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

U.S. slams EU, but Apple tax demand first issued in Washington

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/30/2016 | 11:59pm CEST

BRUSSELS - The United States is furious at the European Union for handing Apple Inc (>> Apple Inc.) a $14.5 billion (11 billion pounds) tax demand on Tuesday but EU officials say it was Washington which put them on to the scheme in the first place.

BRUSSELS - The United States is furious at the European Union for handing Apple Inc (>> Apple Inc.) a $14.5 billion (11 billion pounds) tax demand on Tuesday but EU officials say it was Washington which put them on to the scheme in the first place.

It was a U.S. Senate report in May 2013 revealing the tech giant's deal with the Irish government to rule a big slice of its global earnings untaxable that prompted the European Commission to launch its own inquiries the following month.

The U.S. Treasury said the Commission's order that Apple pay 13 billion euros in back taxes to Ireland - which the company and Dublin are appealing - endangers EU-U.S. economic relations just as efforts to reach a transatlantic free trade pact unravel.

A senior Democratic senator said Brussels had made "a cheap money grab" for U.S. revenues.

But his party colleague who chaired hearings into Apple's taxes three years ago, Carl Levin, said the Europeans were only trying to take what U.S. authorities had failed to claim by not closing loopholes that allowed firms to hoard profits overseas.

"The IRS has failed to stake a claim for U.S. taxes on those revenues," he said in a statement, referring to the U.S. Internal Revenue Service. "So Europe attempts to fill the vacuum. Shame on Apple for dodging U.S. taxes. Shame on the IRS for failing to challenge Apple’s tax avoidance."

For Marcel Fratzscher, president of leading German economic think-tank DIW Berlin and author of a new book on growing inequality, the mudslinging between politicians reflects how global corporations have exploited competition for investment to blunt states' efforts to co-operate against tax avoidance.

"Companies are playing one government against another," he told Reuters.

EU LISTENED TO SENATE

EU Competition Commissioner Margrethe Vestager, a straight-talking Dane who dismisses talk of leading an anti-American crusade, says the hearings at the Senate Permanent Subcommittee on Investigations chaired by Levin were what gave her Spanish predecessor grounds to demand disclosure by Apple and Ireland.

"The Commission listened and decided to look deeper into the matter," Vestager said in June, crediting media reporting and hearings in the British parliament for also providing evidence to help break secrecy around nearly 1,000 cases across Europe.

The Commission said in its judgment on Apple that the United States and other countries were welcome to try and claim some of the unpaid taxes for themselves - highlighting just the complaints of Levin and other senators three years ago when they skewered Apple CEO Tim Cook for failing to bring cash home.

As well as Apple, Starbucks Corp (>> Starbucks Corporation) was ordered to pay more Dutch taxes and Amazon.com Inc (>> Amazon.com, Inc.) and McDonald's Corp (>> McDonald's Corporation) are still being investigated; a series of EU accusations that Google, part of Alphabet Inc (>> Alphabet Inc), has abused its market power have also fuelled complaints from U.S. President Barack Obama's administration that Europe is out to punish American success.

Competition lawyer Pierre Sabbadini said political pressures drove different responses by different authorities. Leaks and public hearings on tax deals had created pressure among voters for the EU to act in 2013, he said, while the size of the companies targeted gave them clout with political leaders, too.

"When investigation-target companies have grown to the size of Apple, they can reach out for political support," he said.

The Obama administration has taken its own action to curb tax avoidance schemes lately. In April, amid public controversy over drug company Pfizer Inc's (>> Pfizer Inc.) proposed merger with Allergan Plc (>> Allergan, Inc.) of Ireland, it announced plans to curb so-called "tax inversions", by which U.S. firms have undertaken cross-border mergers in order to switch to a domicile abroad and so avoid U.S. taxes.

Pfizer abandoned the merger.

(Additional reporting by David Morgan in Washington; Editing by Bill Rigby)

By Foo Yun Chee and Alastair Macdonald

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLERGAN, INC.
08/30 U.S. slams EU, but Apple tax demand first issued in Washington
08/29 ALLERGAN : Intas, Auribindo bid $1b for Teva UK portfolio
08/29 Aurobindo, intas close in on $1-billion teva uk buyout
08/24 Pfizer on buying spree with AstraZeneca antibiotics deal
08/24 ALLERGAN : Gallaher Plastic Surgery & Spa MD Named a Top Practice by Allergan
08/24 ALLERGAN : Assigned Patent
08/22 Pfizer buying maker of prostate-cancer drug Xtandi for $14B
08/17 ALLERGAN : Assigned Patent
08/16 ALLERGAN : Vitenas Cosmetic Surgery Among Top In The Nation
08/15 ALLERGAN : Vitenas Cosmetic Surgery Among Top In The Nation
More news
Sector news : Pharmaceuticals - NEC
02:55aDJWALGREENS BOOTS ALLIANCE : Theranos Walks Away From Zika Test
01:33a ASTRAZENECA : to pay $5.52 million to resolve U.S. SEC foreign bribery case
08/30 U.S. slams EU, but Apple tax demand first issued in Washington
08/30DJFDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30DJNOVARTIS : FDA Approves Novartis's Biosimilar to Amgen's Enbrel
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON16.31%326 855
ROCHE HOLDING LTD.-12.84%214 220
PFIZER INC.8.05%211 570
NOVARTIS AG-10.83%209 772
ASTRAZENECA PLC7.33%174 031
More Results